Lakewood-Amedex (LABT) Director Tucker Receives 33,784-Warrant Grant

What Happened
Tucker Joseph Edward, a director of Lakewood-Amedex Biotherapeutics, was granted 33,784 warrants (a derivative award) on April 24, 2026. The warrants were reported at $0.00 per unit in the Form 4 (so reported acquisition value = $0). This was an award/grant (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: April 24, 2026; reported on Form 4 filed May 6, 2026.
• Instrument and price: 33,784 warrants granted at $0.00 (derivative award).
• Vesting (footnote): Warrants vest in four equal tranches of 8,446 warrants on Oct 24, 2026; Apr 24, 2027; Oct 24, 2027; and Apr 24, 2028.
• Shares owned after transaction: Not specified in this filing.
• Timeliness: Filing date (May 6, 2026) is 12 days after the Apr 24 transaction, which is later than the typical 2-business-day Form 4 filing deadline.

Context
Warrants are a derivative that can be exercised into common shares in the future; vesting must occur before exercise. This grant does not represent a cash purchase and does not indicate an immediate sale of shares. Such board-level awards are common as compensation or incentive; if exercised later, the warrants could increase the company’s share count (potential dilution). This summary is factual and does not speculate on the director’s intentions.